European Archives - Page 995 of 1157 - European Medical Journal

Significance of Diet and Oral Supplementation in Acne Vulgaris

Acne vulgaris is one of the most common skin diseases in the world. There are many factors involved in its pathogenesis. The dermatosis is characterised…

Immunopathogenesis of Leprosy: A Model for T Cell Anergy

Leprosy is a model disease for understanding human immune responses underlying diseases caused by intracellular pathogens, as well as providing valuable…

Reconstructive Options for Cutaneous Defects of the Nose: A Review

Background: The face is the most common site affected by skin cancer in the body and of the facial skin it is the nose that bears the brunt of the attack.

The Main Neonatal Dermatological Findings: A Review

Background: The neonatal period is a phase of adaptation during which several skin conditions can develop. Most of these findings characterise the…

Skin Manifestations Associated with Brucellosis

Brucellosis is a zoonotic infectious disease of worldwide distribution and is still endemic in some developing countries. Brucellosis is a systemic…

Pancreatic Cancer Set to Become Third Biggest Cancer Killer in EU next Year

Vienna, November 7, 2016 – The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.1

EMJ

Novel Signalling Cascade Blockade May Be the Answer to Type 1 Diabetes Prevention

PREVENTION of Type 1 diabetes mellitus (T1DM) development in patients may now be a possibility, according to a paper published by Dr Carolin Daniel and…

EMJ

Do Artificially-Sweetened Drinks Still Increase the Risk of Diabetes?

DIABETES development, particularly Type 2 diabetes mellitus (T2DM), has previously been shown to correlate with sugary drink intake, however a new study…

New App Harnesses Gamification for Smoking Cessation

United Kingdom, November 14, 2016 – A framework to gamify anti-smoking apps, and potentially improve adherence to non-smoking regimens, has been…

EMJ

EAACI Celebrates 60 Years of Influencing Policy and Medical Practice in Europe and Beyond

Florence, 10 November 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) celebrates today in Florence 60 years of successful…